NJU Physicians Selected as New Jersey Monthly’s 2018 Jersey Choice Top Doctors

27 Nov 2018 News

We’re proud to announce that several New Jersey Urology physicians have been named New Jersey Monthly’s 2018 Jersey Choice Top Doctors. More than 24,000 New Jersey doctors were polled on which of their fellow practitioners they consider New Jersey’s best, resulting in the state’s 1,077 Top Doctors, as chosen by their peers.

New Jersey Monthly 2018 Jersey Choice Top Doctors:

View the complete list here >

NJU Physicians Selected as SJ Mag 2018 Top Docs

13 Nov 2018 News

We’re proud to announce that three New Jersey Urology (formerly Delaware Valley Urology) physicians have been named SJ Mag 2018 Top Docs. Two of our physicians were chosen by South Jersey doctors, who were asked to nominate doctors they would recommend to their family members. One of our physicians was nominated by SJ Mag’s readers, who were asked to nominate physicians who they think are Top Docs.

SJ Mag 2018 Top Docs (chosen by South Jersey doctors):

2018 Top Doc Patient Poll (chosen by SJ Mag readers):

Read SJ Mag’s complete list here >

Dr. Scott Asroff Named Best of Burlington County 2018

2 Oct 2018 News

We’re pleased to announce that Scott W. Asroff, MDhas been named a 2018 Best of Burlington County winner by the Burlington County Times.

Honored as an Industry Leader, Dr. Asroff was named “Best Of” in Urology for 2018.  Read the complete list >

The Best of Burlington County is a list, compiled annually, of readers’ favorite businesses, products, and services in the community. More than 130,000 reader votes were cast in 2018.

Dr. Asroff practices general urology, with special interest in male reproductive health, stone disease, and urologic cancers. He practices in BordentownMount Laurel and Willingboro.

To make an appointment, please call 877-388-2778.

J.W. Childs Associates Forms Urology Management Associates with New Jersey Urology

5 Sep 2018 News

New Jersey Urology (NJU), the leading urology service provider in New Jersey, and J.W. Childs Associates (JWC), a leading middle-market private equity firm, have formed Urology Management Associates (UMA) that will provide administrative services to NJU. The establishment of UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services initially in the greater New York metropolitan area with long-range plans to expand nationally.

Recognizing the benefits of scale, NJU recently merged with Delaware Valley Urology (DVU) to become the leading provider of urology services in New Jersey and the largest single-specialty urology group in the U.S. NJU provides complete urologic care and comprehensive individualized treatment for its patients, including men’s health, women’s health and cancer care.

Dr. Lewis Gold and Dr. Mitchell Eisenberg, operating partners at JWC and former President and CEO of Sheridan Healthcare, respectively, will join the board of UMA along with Adam Suttin, Managing Partner, David Fiorentino, Partner and Jeff Miller, Principal. Dr. Gold commented, “We are very excited to collaborate with NJU to continue to develop and expand a best-in-class urology practice management organization.”

Dr. Martin Goldstein, who was appointed President of NJU and Senior Vice President of Corporate Development and Acquisitions of UMA said, “We look forward to working with J.W. Childs Associates on expanding business opportunities for UMA while maintaining NJU’s medical practice independence. JWC’s expertise in managing large-scale practices and UMA’s ability to handle the significant administrative burden of NJU’s non-clinical operations will enable NJU and its physicians to continue to focus on high-quality clinical care to meet the demands of our patients.” Victor Houtz who has been the COO of NJU since 2009 has been named COO at UMA.

The Bloom Organization negotiated on behalf of the NJU and DVU physicians. Mr. Henry Bloom, the founder of The Bloom Organization, said, “Forming UMA shortly after the consummation of the NJU and DVU merger took an incredible effort from all parties and I commend everyone involved. I have represented physicians for the last 30 years and I believe that the growth potential for physician services is better now than I have ever seen. We found a great partner in JWC and its operating executives. I am excited to see this organization execute on its growth strategy in the coming years.”

J.W. Childs Associates is a Boston-based private equity firm focused on investing in middle-market growth companies. Since inception in 1995, JWC has invested $3.7 billion of equity capital in 50 companies across the healthcare, consumer, and specialty retail/e-commerce industries. The firm’s success has been built on its industry focus and the extensive operating expertise of its partners.

The Bloom Organization advised NJU on the transaction with DLA Piper LLP serving as its legal counsel. McDermott Will & Emery LLP advised J.W. Childs.

Join NJU for a ZERO Prostate Cancer Run/Walk this Fall

22 Aug 2018 News

New Jersey Urology is proud to present South Jersey’s ZERO Prostate Cancer Run/Walk to help end prostate cancer.

When: Sunday, November 4th | 9 a.m.
Where: Valenzano Winery (1090 Route 206, Shamong, NJ 08088)

The 2018 ZERO Prostate Cancer Run/Walk – South Jersey features a 5K run/walk, 1-mile walk, Kids’ Superhero Dash for Dad, and virtual Snooze for Dudes program. Stick around for the family-friendly post-race celebration. Run/walk participants will receive shirts, free food and prizes, and the opportunity to connect with others who are impacted by prostate cancer. 5K and 1 Mile participants 21 and over (must show valid id) will receive a free wine glass and wine on race day.

The funds raised from 2018 ZERO Prostate Cancer Run/Walk – South Jersey are invested around the country to provide research for new prostate cancer treatments, free prostate cancer testing, and education for men and families about prostate cancer. No other prostate cancer charity spends more per dollar on programs – more than 85 cents. ZERO puts every donation to good use.


NJU Physicians Selected as South Jersey Magazine 2018 Top Physicians

10 Aug 2018 News

We’re proud to announce that two New Jersey Urology (formerly Delaware Valley Urology) physicians have been honored as South Jersey Magazine 2018 Top Physicians. These physicians were chosen by South Jersey Magazine readers, who were asked to nominate doctors who made a lasting impact. South Jersey Magazine also asked area hospitals and medical providers to nominate a select group of doctors they feel are worthy of the spotlight because of their dedication to their patients and their commitment to advancing health care in South Jersey.

South Jersey Magazine 2018 Top Physicians:

Read South Jersey Magazine’s complete list here >

Dr. Brian E. Weiss Joins New Jersey Urology

1 Aug 2018 News

We’re pleased to announce Brian E. Weiss, MD has joined our team in South Jersey.

Dr. Weiss has an undergraduate degree from the Wharton School at the University of Pennsylvania. He spent several years working in finance and biotechnology prior to entering medical school.

After receiving his medical degree from the Perelman School of Medicine at the University of Pennsylvania, he completed a surgical internship and urologic surgical residency at New York University Langone Medical Center in New York City. He complemented his training with a fellowship in Endourology, Laparoscopy and Robotic Surgery at Urology of Virginia/Eastern Virginia Medical School in Virginia Beach.

Dr. Weiss has a special interest in endourology, stone disease, and urologic oncology. He will practice in our Marlton and Mount Laurel offices.

To make an appointment, please call 877-388-2778.

New Jersey Urology Offers Innovative Program for Early Detection and Treatment of Enlarged Prostate

29 May 2018 News

New Care Pathway Program Uses Data Analytics to Improve Patient Outcomes

New Jersey Urology announced that their practice will now offer an innovative BPH Care Pathway program for the early detection and treatment of men with an enlarged prostate, also called Benign Prostatic Hyperplasia (BPH). New Jersey Urology is the first in New Jersey to participate in this unique approach that combines patient education with data analytics to determine the best treatment options for men who have or are at risk of developing BPH. New Jersey Urology is recognized as a leader in the Delaware Valley region, providing exemplary care for men suffering from problems associated with Lower Urinary Tract Symptoms (LUTS).

The BPH Care Pathway Program is designed to provide targeted care to men who are at risk for BPH, a condition that affects 50 percent of men over the age of 50. Through data analytics, the program identifies patients with characteristics associated with BPH to detect the early onset or worsening of symptoms. Care teams for New Jersey Urology are able to communicate with patients proactively to accelerate the assessment of treatment options. The program has the potential to reduce overall healthcare expenses as a result of treating patients before symptoms worsen or complications occur.

“The BPH Care Pathway empowers patients with more insights into their condition, producing better health outcomes. When a patient is made fully aware of all of their options, everyone benefits,” said Dr. Thomas Mueller. “We are excited about this approach, which will help men achieve a higher quality of life. We believe this will become the new standard of care used by many physicians.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

“Many men suffer from the negative side effects of BPH medications and their quality of life is significantly impacted,” said Dr. David Sussman. “We want to give those patients a better alternative and the BPH Care Pathway allows for us to have these conversations. There are treatments available to men that are truly minimally invasive and very effective. But, our goal prior to implementation is to hone in on a comprehensive care assessment, and then fully educate them about their options.”

NJU Physicians Selected as Philadelphia Magazine 2018 Top Doctors

2 May 2018 News

We’re proud to announce that three New Jersey Urology (formerly Delaware Valley Urology) physicians have been honored as Philadelphia Magazine 2018 Top Doctors. These physicians were nominated by their peers as the very best in their field, and were carefully screened and vetted for educational and professional experience before being selected.

Philadelphia Magazine 2018 Top Doctors:

Read Philly Mag’s complete list here >


Dr. Arvind Srinivasan Joins New Jersey Urology

1 May 2018 News

We’re pleased to announce that Arvind Srinivasan, MD has joined our team in South Jersey.

Dr. Srinivasan earned his medical degree from Rutgers-Robert Wood Johnson Medical School in Piscataway, NJ. He then completed his Residency at Geisinger Medical Center in Danville, Pennsylvania and his Internship at Morristown Memorial Hospital in Morristown, New Jersey.

Dr. Srinivasan is a Fellow of the American College of Surgeons and member of the American Urological Association. He is board certified by the American Board of Urology.

Dr. Srinivasan practices exclusively at the AtlantiCare Health Park in Egg Harbor Township.

1 2 3 4


Skip to content